XL413 (BMS-863233) 1169562-71-3
Descrição do produto
.cp_wz table {border-top: 1px solid #ccc; border-left: 1px solid #ccc; } .cp_wz table td {border-right: 1px solid #ccc; borda inferior: 1px sólido #ccc; preenchimento: 5px 0px 0px 5px;} .cp_wz tabela th {border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; preenchimento: 5px 0px 0px 5px;} \ n Peso molecular: \ n 326,18 XL413 (BMS-863233) é um inibidor de quinase homólogo (CDC7) do ciclo 7 de divisão celular potente e seletivo com IC50 de 3,4 nM, mostrando 63-, 12- e Seletividade de 35 vezes sobre CK2, Pim-1 e pMCM2, respectivamente. Fase 1/2. \ n Atividade biológica
Ensaio de cinase de protocolo (apenas para referência): [1]
Ensaio de células: [1]
Estudo Animal: [1]
Conversão de diferentes modelos de animais com base em BSA (valor com base em dados das diretrizes preliminares da FDA)
Por exemplo, para modificar a dose de resveratrol usada para um camundongo (22,4 mg / kg) para uma dose baseada na BSA para um rato, multiplique 22,4 mg / kg pelo fator Km para um camundongo e, em seguida, divida pelo fator Km para um rato. Este cálculo resulta em uma dose equivalente de rato para o resveratrol de 11,2 mg / kg.
Informação Química
Calculadora de molaridade Calculadora de diluição Calculadora de peso molecular
Description | XL413 (BMS-863233) is a potent and selective cell division cycle 7 homolog (CDC7) kinase inhibitor with IC50 of 3.4 nM, showing 63-, 12- and 35-fold selectivity over CK2, Pim-1 and pMCM2, respectively. Phase 1/2. | |||||
---|---|---|---|---|---|---|
Targets | Cdc7 [1] | Pim1 [1] | CK2 [1] | |||
IC50 | 3.4 nM | 42 nM | 212 nM | |||
In vitro | In MDA-MB-231T and Colo-205 cell lines, XL413 results in inhibition of CDC7 specific phosphorylation of MCM2. XL413 also inhibits the cell proliferation, decreases cell viability and elicits the caspase 3/7 activity in Colo-205 cells. Moreover, XL413 results in modified S phase progression that subsequently leads to apoptotic cell death. | |||||
In vivo | In a Colo-205 xenograft model, XL413, at the 3 mg/kg dose, causes 70% inhibition of phosphorylated MCM2, and causes significant tumor growth regression at the 100 mg/kg dose. | |||||
Features |
|
CDC7 kinase assay | Kinase activity and compound inhibition are determined using the luciferase-luciferin-coupled chemiluminescence assay and measured as the percentage of ATP utilized following the kinase reaction in a 384-well format. The final CDC7 kinase assay condition is 6 nM CDC7/ASK, 1 μM ATP, 50 mM Hepes pH 7.4, 10 mM MgCl2, 0.02% BSA, 0.02% brij 35, 0.02% tween 20 and 1 mM DTT. It is worthy to note that the CDC7/ASK protein exhibits substrate-independent ATP utilization. All kinase reactions are incubated at room temperature for 1-2 h. |
---|
Cell lines | Colo-205 cells |
---|---|
Concentrations | ~10 μM |
Incubation Time | 24 hours |
Method | The cell proliferation is measured by BrdU incorporation assay, and viability is assayed by Cell Titer–Glo kits. |
Animal Models | Mice bearing Colo-205 xenografts |
---|---|
Formulation |
|
Dosages | ~100 mg/kg |
Administration | p.o. |
Species | Baboon | Dog | Monkey | Rabbit | Guinea pig | Rat | Hamster | Mouse |
Weight (kg) | 12 | 10 | 3 | 1.8 | 0.4 | 0.15 | 0.08 | 0.02 |
Body Surface Area (m2) | 0.6 | 0.5 | 0.24 | 0.15 | 0.05 | 0.025 | 0.02 | 0.007 |
Km factor | 20 | 20 | 12 | 12 | 8 | 6 | 5 | 3 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
Rat dose (mg/kg) = mouse dose (22.4 mg/kg) × | mouse Km(3) | = 11.2 mg/kg |
rat Km(6) |
Molecular Weight (MW) | 326.18 |
---|---|
Formula |
C14H13Cl2N3O2 |
CAS No. | 1169562-71-3 |
Storage | 3 years -20℃Powder |
---|---|
6 months-80℃in solvent (DMSO, water, etc.) | |
Synonyms | N/A |
Solubility (25°C) * | In vitro | DMSO | <1 mg/mL ( |
---|---|---|---|
Water | 46 mg/mL heating (141.02 mM) | ||
Ethanol | <1 mg/mL ( | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Chemical Name | Benzofuro[3,2-d]pyrimidin-4(3H)-one, 8-chloro-2-(2S)-2-pyrrolidinyl-, hydrochloride |
---|
Grupo de Produto : Ciclo de célula > Inibidor CDK
outros produtos
produtos quentes
Astragalosídeo AClortetraciclina HCl 64-72-2Paclitaxel 33069-62-4Acetato de dexametasona 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatran (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorato isopropil (XL335) 629664-81-9BMS-378806 357263-13-9